Oral drug normalizes blood potassium in 98 percent of kidney patients
Monday, March 30, 2015 - 20:30
in Health & Medicine
A medication called ZS-9 normalized potassium in the blood of 98 percent of chronic kidney disease patients treated for hyperkalemia. Hyperkalemia is high potassium in the blood, and may occur as a side effect of taking kidney disease medications called Renin Angiotensin Aldosterone System inhibitors. Hyperkalemia increases the risk of cardiac arrhythmias.